thiabendazole has been researched along with Lupus Erythematosus, Systemic in 2 studies
Tresaderm: dermatologic soln containing dexamethasone, thiabendazole & neomycin sulfate
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Panyathanya, R | 1 |
| Sriumpai, S | 1 |
| Tantranond, R | 1 |
| Rivera, E | 1 |
| Maldonado, N | 1 |
| Vélez-García, E | 1 |
| Grillo, AJ | 1 |
| Malaret, G | 1 |
2 other studies available for thiabendazole and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Fatal strongyloidiasis in Siriraj Hospital, Bangkok, Thailand.
Topics: Adult; Child, Preschool; Female; Humans; Immunosuppression Therapy; Infant; Lupus Erythematosus, Sys | 1983 |
Hyperinfection syndrome with Strongyloides stercoralis.
Topics: Adult; Aged; Autopsy; Female; Hodgkin Disease; Humans; Infections; Leprosy; Leukemia, Lymphoid; Lupu | 1970 |